Follistim AQ (follitropin beta injection)

DECEMBER 01, 2005

Organon Pharmaceuticals USA (Roseland, NJ) recently announced the availability of Follistim AQ in 75-internationalunit (IU) and 150-IU presentations in single-use 0.5-mL vials in premixed solutions, thus eliminating reconstitution. Follistim AQ is indicated for the development of multiple follicles in ovulatory patients participating in an assisted reproductive technology (ART) program. The product also is indicated for the induction of ovulation and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure. The additional presentations complement Organon's existing fertility product portfolio of the Follistim AQ Cartridge in 300-, 600-, and 900-IU strengths, which are designed to be used with the Follistim Pen. For patients participating in the ART program, a starting dose of 150 to 225 IU of Follistim AQ is recommended for at least the first 4 days of treatment. The recommended starting dose of Follistim AQ for ovulation induction is 75 IU for up to 14 days. For more information, visit www.follistim.com, or call 800-241-8812.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.